Completion of Facility Enables Initiation of Phase 3 Clinical Trial of Nepafenac in Patients Undergoing Cataract Surgery AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") ...
Introducing the New SOFT PLUG(R) Extended Duration 180-T Tapered Plug GLENDORA, Calif., April 6, 2024 /PRNewswire/ -- OASIS(R) Medical Inc., manufacturer and distributor of disposable surgical ...
Please provide your email address to receive an email when new articles are posted on . Among preoperative treatments to be considered are use of oral antivirals, continuation of topical steroids, ...
Industry Veteran with over 30 years of ophthalmic experience to guide development and commercial efforts for Mati's expanding late-stage pipeline, including two products about to enter Phase III ...
AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") announced that it has completed and now occupies a facility dedicated to manufacturing all products formulated in Mati's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results